Page last updated: 2024-08-23

bucindolol and Chronic Illness

bucindolol has been researched along with Chronic Illness in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (11.11)18.2507
2000's6 (66.67)29.6817
2010's2 (22.22)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aban, IB; Ahmed, A; Ahmed, MI; Aronow, WS; Bogaard, HJ; Deedwania, P; Desai, RV; Feller, MA; Fonarow, GC; Guichard, JL; Iskandrian, AE; Meyer, P; Mujib, M; Waagstein, F; White, M1
Fiuzat, M; O'Connor, CM1
Coats, AJ1
Abraham, WT; Bristow, MR; Crisman, TS; Gilbert, EM; Hattler, BG; Larrabee, P; Lowes, BD; Robertson, AD; White, M; Yoshikawa, T1
Bristow, MR1
Bristow, MR; Domanski, MJ; Eichhorn, EJ; Krause-Steinrauf, H; Lavori, PW1
SoRelle, R1
Bosimini, E1
Czuriga, I; Edes, I1

Reviews

4 review(s) available for bucindolol and Chronic Illness

ArticleYear
Bucindolol: new hopes from reviewing past data.
    Drugs of today (Barcelona, Spain : 1998), 2011, Volume: 47, Issue:5

    Topics: Adrenergic beta-Antagonists; Chronic Disease; Clinical Trials as Topic; Heart Failure; Humans; Propanolamines

2011
Beta-adrenoceptor antagonists in elderly patients with chronic heart failure: therapeutic potential of third-generation agents.
    Drugs & aging, 2006, Volume: 23, Issue:2

    Topics: Adrenergic beta-Antagonists; Age Factors; Aged; Benzopyrans; Carbazoles; Carvedilol; Chronic Disease; Ethanolamines; Heart Failure; Humans; Nebivolol; Practice Guidelines as Topic; Propanolamines; Randomized Controlled Trials as Topic

2006
beta-adrenergic receptor blockade in chronic heart failure.
    Circulation, 2000, Feb-08, Volume: 101, Issue:5

    Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Chronic Disease; Heart Failure; Heart Function Tests; Humans; Metoprolol; Propanolamines; Receptors, Adrenergic, beta; Signal Transduction

2000
[Role of beta-blockers in the treatment of chronic heart heart failure].
    Orvosi hetilap, 2001, Sep-16, Volume: 142, Issue:37

    Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Chronic Disease; Controlled Clinical Trials as Topic; Disease Progression; Drug Administration Schedule; Heart Failure; Humans; Metoprolol; Myocardial Contraction; Patient Selection; Propanolamines; Survival Rate; Ventricular Dysfunction, Left; Ventricular Function, Left

2001

Trials

3 trial(s) available for bucindolol and Chronic Illness

ArticleYear
Reduced right ventricular ejection fraction and increased mortality in chronic systolic heart failure patients receiving β-blockers: insights from the BEST trial.
    International journal of cardiology, 2013, Feb-10, Volume: 163, Issue:1

    Topics: Adrenergic beta-Antagonists; Aged; Chronic Disease; Female; Heart Failure, Systolic; Humans; Male; Middle Aged; Propanolamines; Stroke Volume; Treatment Outcome; Ventricular Function, Right

2013
Second- and third-generation beta-blocking drugs in chronic heart failure.
    Cardiovascular drugs and therapy, 1997, Volume: 11 Suppl 1

    Topics: Adrenergic beta-Antagonists; Adult; Aged; Carbazoles; Cardiac Output, Low; Cardiomyopathy, Dilated; Carvedilol; Chronic Disease; Exercise Test; Heart Ventricles; Hemodynamics; Humans; Metoprolol; Middle Aged; Myocardial Ischemia; Oxygen Consumption; Propanolamines; Ventricular Function, Left

1997
A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure.
    The New England journal of medicine, 2001, 05-31, Volume: 344, Issue:22

    Topics: Adrenergic beta-Antagonists; Aged; Chronic Disease; Double-Blind Method; Female; Heart Failure; Heart Transplantation; Hospitalization; Humans; Male; Middle Aged; Propanolamines; Proportional Hazards Models; Severity of Illness Index; Survival Analysis

2001

Other Studies

2 other study(ies) available for bucindolol and Chronic Illness

ArticleYear
Beta-blocker trials seem to be in conflict.
    Circulation, 2001, Jun-12, Volume: 103, Issue:23

    Topics: Adrenergic beta-Antagonists; Carbazoles; Carvedilol; Chronic Disease; Contraindications; Heart Failure; Humans; Propanolamines; Randomized Controlled Trials as Topic; Survival Rate; Treatment Outcome

2001
[Effect of carvedilol on survival in severe chronic heart failure. A trial of the beta-blocker bucindolol in patient with advanced heart failure].
    Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology, 2001, Volume: 2, Issue:8

    Topics: Adrenergic beta-Antagonists; Carbazoles; Carvedilol; Chronic Disease; Clinical Trials as Topic; Heart Failure; Humans; Propanolamines; Severity of Illness Index; Survival Rate

2001